Beyond Lyme: How Treg Apheresis Addresses the Whole Chronic Illness Picture

If your case is "complicated" — if you have more than just Lyme — you may be exactly the patient who benefits most from an upstream approach.

Most patients who come to the Lyme Immunotherapy Center don't have a simple, isolated diagnosis. They have Lyme and coinfections. Or long COVID layered on top of years of tick-borne illness. Or chronic Epstein-Barr reactivation with autoimmune features. Or mold exposure on top of everything else.

They've been told their case is "complicated." They've been bounced between specialists, each treating one piece of the picture while the patient never fully recovers.

There's a reason for that pattern. And understanding it changes how you think about treatment.

The Shared Upstream Driver

Despite looking different on the surface, many chronic complex illnesses share a common underlying mechanism: dysregulated immune signaling and depleted T-regulatory cell function. The immune system has lost its ability to modulate itself, leaving the body in a state of chronic inflammation, misfiring responses, and exhaustion.

This pattern — Treg depletion leading to unresolved immune activation — doesn't belong exclusively to Lyme disease. Research published in Frontiers in Immunology confirmed it in Long COVID patients: single-cell analysis revealed a marked reduction in regulatory T cells, accompanied by expansion of effector T cells and chronic immune activation patterns — a picture nearly identical to what's documented in chronic tick-borne illness. Based on articles retrieved from PubMed: DOI: 10.3389/fimmu.2026.1745933

Conventional medicine treats each diagnosis separately — one specialist for Lyme, another for the coinfections, another for the post-COVID symptoms — and the patient never gets to the root. Because the root is upstream of all of them.

Conditions That Share This Immune Signature

Patients with the following conditions often present with the same pattern of regulatory T-cell depletion and chronic immune dysregulation:

• Lyme disease and post-treatment Lyme disease syndrome
• Bartonella and Babesia coinfections — part of the standard chronic tick-borne illness picture, and associated with particularly profound immune dysregulation
• Long COVID / post-acute COVID syndrome — emerging research shows Treg reduction and T cell exhaustion as consistent findings
• Chronic mold illness and CIRS — patients frequently present with the same inflammatory dysregulation pattern
• Chronic Epstein-Barr virus reactivation — persistent viral activation driving ongoing immune burden
• Broader post-infectious immune dysregulation across multiple triggers

The important framing: patients with these conditions often share a common pattern of immune dysregulation. That's a mechanism-level observation, not a claim that Treg apheresis treats any of these conditions specifically by name.

Why This Helps Patients with Overlapping Diagnoses

When the immune system can regulate itself again, the body stops misfiring in response to every trigger. Inflammation comes down. The body becomes more capable of handling residual pathogens, toxins, and stressors. Other supportive therapies — whether for mold, EBV, or anything else — work better because the immune foundation has been restored.

For patients with Bartonella and Babesia coinfections specifically: these are part of the standard chronic Lyme complex picture. Patients with coinfections often have particularly profound immune dysregulation — because they're carrying multiple simultaneous infectious triggers, each one contributing to the Treg depletion. Restoring Treg function is foundational to addressing the full coinfection picture, not just the Lyme component.

For patients with long COVID, mold illness, or chronic viral activation: the mechanism is the same, even if the trigger is different. Restoring immune regulation addresses a core driver of ongoing symptoms — and creates the conditions in which targeted therapies for each specific diagnosis can actually work.

If Your Case Is Complicated — You May Be Exactly Who This Is For

The patients who have often suffered longest and been failed most by conventional medicine are the ones with overlapping diagnoses, multiple triggers, and immune systems that have been dysregulated across multiple fronts simultaneously.

Those patients are not poor candidates for an upstream immune intervention. They're often the best candidates — because the common thread running through all of their diagnoses is the same immune regulatory failure that Treg apheresis directly addresses.

A thorough clinical review is essential. Not every patient with these conditions is a candidate. The medical team at the Immunotherapy Institute evaluates each case individually to determine fit — because complexity requires individualized assessment, not a generic protocol.

But if you've been told your case is complicated, and you've been bounced between specialists without getting well — it may be worth asking whether the answer is upstream of all the diagnoses you've been given.